CLOs on the Move

NovaSom

www.novasom.com

 
NovaSom is a privately held diagnostic-service provider for home testing and evaluation of obstructive sleep apnea (OSA). As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use for the diagnosis of sleep apnea, with clinically proven equivalence * to conventional polysomnography (PSG). NovaSom works with physicians, private insurers, government and public health organizations to address concerns about the large numbers of individuals with undiagnosed sleep apnea. It is our shared concern that millions of Americans are utilizing more health care resources and incurring greater health care costs because their OSA ...
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.novasom.com
  • 801 Cromwell Park Drive Suite 108
    Glen Burnie, MD USA 21061
  • Phone: 877.753.3776

Executives

Name Title Contact Details

Similar Companies

Lifetime Cancer Screen and Dgnst

Lifetime Cancer Screen and Dgnst is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

better health usa

better health usa is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dynacare Laboratories

Dynacare Laboratories is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Health Lab

American Health Lab is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeoGenomics

NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics` extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation.